ArticleBMC psychiatry2026
Post-infectious psychiatric symptoms and diagnoses in children and adolescents following COVID-19.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgrounThe Coronavirus Disease 2019 (COVID-19) pandemic has substantially disrupted the lives of children and adolescents, raising concerns about increased psychiatric morbidity. This study examined post-COVID psychiatric symptoms in a pediatric population and explored associated risk factors.
methodsThis follow-up study enrolled 107 children and adolescents (6-18 years) with laboratory-confirmed COVID-19, retrospectively identified from Gülhane Training and Research Hospital records, contacted via telephone, and invited for in-person pediatric examination and Revised Child Anxiety and Depression Scale (RCADS) screening. Participants with T-scores ≥65 were referred to Gazi University for face-to-face psychiatric evaluation by child psychiatrists using DSM-5 criteria. Sociodemographic and clinical variables were analyzed for associations with elevated RCADS scores. Receiver operating characteristic (ROC) analyses were performed using DSM-5-based clinical diagnoses as the reference standard.
resultsThe cohort included 62 females (57.9%) and 45 males (42.1%), with a mean age of 12.3±3.1 years. Most participants were symptomatic during infection (90.7%), and 35.5% developed at least one COVID-related complication, most commonly taste loss (29.0%). Post-COVID psychiatric symptoms were reported in 56.1% of cases, predominantly attention difficulties (28.9%) and irritability (23.3%). Approximately half (52.2%) of children without prior history of psychiatric symptoms developed at least one new symptom. Higher anxiety and depression scores were significantly associated with prematurity, birth complications, and pre-existing psychiatric symptoms. In ROC analyses, the parent-reported total anxiety score showed an area under the curve (AUC) of 0.92 with an optimal cut-off of 60 (sensitivity 81.5%, specificity 93.8%), while the child-reported score showed an AUC of 0.90 with an optimal cut-off of 65 (sensitivity 70.4%, specificity 93.8%). Children without psychiatric history had significantly lower scores (p < 0.001).
conclusionsCOVID-19 was linked to increased psychiatric symptoms in children, with prematurity, birth complications, and prior history as key risks. RCADS proved sensitive for screening, emphasizing targeted interventions post-infection. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.